{"title":"네이버 금융 ─ 뉴스 ─ 기업 종목분석","url":"https://finance.naver.com/news/news_list.naver?mode=LSS3D&section_id=101&section_id2=258&section_id3=402","favicon":"https://finance.naver.com/news/favicon.ico","elements":[{"title":"두달새 주가 3배·거래량 100배···비덴트 어디까지 갈까","contents":"<a href=\"/news/news_read.naver?article_id=0003990129&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211126&amp;page=1\" title=\"두달새 주가 3배·거래량 100배···비덴트 어디까지 갈까\">두달새 주가 3배·거래량 100배···비덴트 어디까지 갈까</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0003990129&office_id=011&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211126&page=1","retrieved":1637917478854},{"title":"델타보다 센 '누' 변이 아시아 증시도 덮쳤다","contents":"<a href=\"/news/news_read.naver?article_id=0003990128&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211126&amp;page=1\" title=\"델타보다 센 '누' 변이 아시아 증시도 덮쳤다\">델타보다 센 '누' 변이 아시아 증시도 덮쳤다</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0003990128&office_id=011&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211126&page=1","retrieved":1637917478855},{"title":"“내년엔 반격 시작”... 美 독주에 가려졌던 신흥국펀드 해뜰까","contents":"<a href=\"/news/news_read.naver?article_id=0003990122&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211126&amp;page=1\" title=\"“내년엔 반격 시작”... 美 독주에 가려졌던 신흥국펀드 해뜰까\">“내년엔 반격 시작”... 美 독주에 가려졌던 신흥국펀드 해뜰까</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0003990122&office_id=011&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211126&page=1","retrieved":1637917478855},{"title":"꿈틀대던 대형주에 찬물···바이오 등 코로나 수혜주 '홀로 급등'","contents":"<a href=\"/news/news_read.naver?article_id=0003990116&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211126&amp;page=1\" title=\"꿈틀대던 대형주에 찬물···바이오 등 코로나 수혜주 '홀로 급등'\">꿈틀대던 대형주에 찬물···바이오 등 코로나 수혜주 '홀로 급등'</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0003990116&office_id=011&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211126&page=1","retrieved":1637917478857},{"title":"[펀드줌인]글로벌 대체투자인컴펀드, 해외 우량 인프라·리츠에 투자","contents":"<a href=\"/news/news_read.naver?article_id=0003990112&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211126&amp;page=1\" title=\"[펀드줌인]글로벌 대체투자인컴펀드, 해외 우량 인프라·리츠에 투자\">[펀드줌인]글로벌 대체투자인컴펀드, 해외 우량 인프라·리츠에 투자</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0003990112&office_id=011&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211126&page=1","retrieved":1637917478858},{"title":"'분할 재상장' SK스퀘어…자회사 IPO가 주가 좌우","contents":"<a href=\"/news/news_read.naver?article_id=0004885054&amp;office_id=009&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211126&amp;page=1\" title=\"'분할 재상장' SK스퀘어…자회사 IPO가 주가 좌우\">'분할 재상장' SK스퀘어…자회사 IPO가 주가 좌우</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004885054&office_id=009&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211126&page=1","retrieved":1637917478859},{"title":"반도체 기판株 훈풍…\"내년은 더 좋다\"","contents":"<a href=\"/news/news_read.naver?article_id=0004633466&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211126&amp;page=1\" title=\"반도체 기판株 훈풍…&quot;내년은 더 좋다&quot;\">반도체 기판株 훈풍…\"내년은 더 좋다\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004633466&office_id=015&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211126&page=1","retrieved":1637917478860}]}